These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Effusanin C inhibits inflammatory responses via blocking NF-κB and MAPK signaling in monocytes. Author: Kim JY, Kim HS, Kim YJ, Lee HK, Kim JS, Kang JS, Hong JT, Kim Y, Hwang BY, Han SB. Journal: Int Immunopharmacol; 2013 Jan; 15(1):84-8. PubMed ID: 23159337. Abstract: Effusanin C, a constituent of Isodon japonicus, has been used in oriental countries as a traditional folk medicine to treat inflammatory diseases, but its mechanism of action remains unknown. Here, we investigate the inhibitory activity of effusanin C in inflammatory monocytes. Effusanin C markedly inhibited the production of inflammatory mediators including nitric oxide, IL-1β, and TNF-α in macrophages and dendritic cells. Furthermore, molecular studies showed that effusanin C inhibited phosphorylation of p38, JNK, and ERK, degradation of IκBβ, and nuclear translocation of NF-κB p50/p65 in these cells. Taken together, these data show that effusanin C inhibits inflammatory responses by blocking NF-κB and MAPK signalings in monocytes.[Abstract] [Full Text] [Related] [New Search]